Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

109.18 +10.62 (+10.78%)
Official Closing Price Updated: 7:59 PM EST, Nov 25, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Moderna Inc

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Thinking about buying stock in Altimmune, General Electric, Moderna, Delta Air Lines, or Norwegian Cruise Line?
InvestorsObserver issues critical PriceWatch Alerts for ALT, GE, MRNA, DAL, and NCLH. 
From PR Newswire
Moderna Announces the European Commission’s Approval of Advance Purchase Agreement for Initial 80 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)
Moderna announces the European Commission’s approval of advance purchase agreement for initial 80 million doses of mRNA vaccine against COVID-19 
From Business Wire News Releases
More Stringent Testing is Needed as Regions Head for More Lockdowns
- FinancialBuzz.com News Commentary 
From PR Newswire
Thinking about buying stock in HTG Molecular Diagnostics, Moderna, FuelCell Energy, BioNTech, or Blink Charging?
InvestorsObserver issues critical PriceWatch Alerts for HTGM, MRNA, FCEL, BNTX, and BLNK. 
From PR Newswire
Thinking about trading options or stock in JOYY Inc, Moderna, Fiserv, L Brands, or Nikola Corp?
InvestorsObserver issues critical PriceWatch Alerts for YY, MRNA, FISV, LB, and NKLA. 
From PR Newswire
Rising Number of Cases Reinforces the Need for Comprehensive Diagnostics
FinancialBuzz.com News Commentary 
From PR Newswire
Thinking about buying stock in Pfizer, Moderna, Micro Focus, Riot Blockchain, or PG&E Corp?
InvestorsObserver issues critical PriceWatch Alerts for PFE, MRNA, MFGP, RIOT, and PCG. 
From PR Newswire
Vitally Important COVID-19 Test Kit Market Could Exceed $15 Billion This Year Alone
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Vitally Important COVID-19 Test Kit Market Could Exceed $15 Billion This Year Alone
FinancialNewsMedia.com News Commentary 
From PR Newswire
European Medicines Agency Begins Rolling Review of Moderna’s mRNA Vaccine Candidate Against COVID-19 (mRNA-1273)
European Medicines Agency begins rolling review of Moderna’s mRNA vaccine candidate against COVID-19 (mRNA-1273). 
From Business Wire News Releases
Moderna Announces Supply Agreement with United Kingdom Government to Supply mRNA Vaccine Against COVID-19 (mRNA-1273) if Approved for Use
Moderna announces supply agreement with United Kingdom government to supply mRNA vaccine against COVID-19 (mRNA-1273) if approved for use 
From Business Wire News Releases
Thinking about buying stock in Pfizer, Moderna, Inovio Pharmaceuticals, AMC Entertainment, or HighPoint Resources?
InvestorsObserver issues critical PriceWatch Alerts for PFE, MRNA, INO, AMC, and HPR. 
From PR Newswire
Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study
Moderna’s COVID-19 vaccine candidate meets its primary efficacy endpoint in the first interim analysis of the Phase 3 COVE study 
From Business Wire News Releases
Moderna Announces Longer Shelf Life for its COVID-19 Vaccine Candidate at Refrigerated Temperatures
Moderna announces longer shelf life for its COVID-19 vaccine candidate at refrigerated temperatures 
From Business Wire News Releases
Swissmedic Begins Rolling Review of Moderna’s mRNA Vaccine Against COVID-19 (mRNA-1273)
Swissmedic begins rolling review of Moderna’s mRNA vaccine against COVID-19 (mRNA-1273). 
From Business Wire News Releases
Thinking about buying stock in Moderna, ACCO Brands, Top Ships, JD.Com, or Xpeng?
InvestorsObserver issues critical PriceWatch Alerts for MRNA, ACCO, TOPS, JD, and XPEV. 
From PR Newswire
Moderna Has Completed Case Accrual for First Planned Interim Analysis of its mRNA Vaccine Against COVID-19 (mRNA-1273)
Moderna has completed case accrual for first planned interim analysis of its mRNA vaccine against COVID-19 (mRNA-1273). 
From Business Wire News Releases
Should you invest in American Airlines, Microsoft, Plug Power, Sorrento Therapeutics, or Moderna?
InvestorsObserver issues critical PriceWatch Alerts for AAL, MSFT, PLUG, SRNE, and MRNA. 
From PR Newswire
Moderna Announces Clinical Updates on Personalized Cancer Vaccine Program
Moderna announces clinical updates on Personalized Cancer Vaccine program 
From Business Wire News Releases
Covid-19 Resurgence Leading to Increasing Demand For Automated UV-C Light-Based Surface Disinfection Systems
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Covid-19 Resurgence Leading to Increasing Demand For Automated UV-C Light-Based Surface Disinfection Systems
Financialnewsmedia.com News Commentary 
From PR Newswire
2nd Annual Gabelli Funds – Columbia Business School Healthcare Symposium (Virtual) – Friday, November 13, 2020
Join us as we discuss today’s pressing healthcare issues. 
From Business Wire News Releases
Vaccine Development Holdups Reinforce the Need for Interim Solutions
FinancialBuzz.com News Commentary 
From PR Newswire
Moderna to Present at Upcoming Investor Conferences in November 2020
Moderna to present at upcoming investor conferences in November 2020. 
From Business Wire News Releases
Moderna Named Top Employer by Science for Sixth Consecutive Year
Moderna named top employer by Science for sixth consecutive year. 
From Business Wire News Releases
Thinking about trading options or stock in Moderna, Nio, Overstock.com, Marvell Technology, or Walt Disney?
InvestorsObserver issues critical PriceWatch Alerts for MRNA, NIO, OSTK, MRVL, and DIS. 
From PR Newswire
Moderna Reports Third Quarter 2020 Financial Results and Provides Business Updates
Moderna reports third quarter 2020 financial results and provides business updates. 
From Business Wire News Releases
Moderna Partners with Takeda and the Government of Japan to Supply 50 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273) to Japan
Moderna partners with Takeda and the government of Japan to supply 50 million doses of mRNA vaccine against COVID-19 (mRNA-1273) to Japan. 
From Business Wire News Releases
UVC Radiation Devices & Disinfection Solutions Playing Major Role in Barrier Approach for Reducing Viruses
Financialnewsmedia.com News Commentary 
From PR Newswire
UVC Radiation Devices & Disinfection Solutions Playing Major Role in Barrier Approach for Reducing Viruses
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.